CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
USD |
NASDAQ |
Mar 21, 16:00
CymaBay Therapeutics Price to Book Value: 12.76 for March 25, 2024
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Gilead Sciences, Inc. | 7.146 |
| Assure Holdings Corp. | -- |
| Societal CDMO Inc (DELISTED) | 1.982 |
| AN2 Therapeutics, Inc. | 0.5945 |
| Madrigal Pharmaceuticals, Inc. | 18.34 |
Price to Book Value Related Metrics
| Earnings Yield | -3.05% |